Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1992-01-07
1993-11-30
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530351, A61K 3700, A61K 3766
Patent
active
052663124
ABSTRACT:
The invention relates to a method for a steroid resistant condition via administration of gamma interferon to a subject, such as a human, afflicted with the condition. The gamma interferon is administered in an amount sufficient to alleviate at least one parameter associated with the steroid resistant condition.
REFERENCES:
patent: 4944941 (1990-07-01), Ammarn
Kamada, A. K. et al. "Steroid Resistance in Asthma: our current understanding" Pediatric Pulmonology, 00:000-000 (1992) pp. 1-7.
Boguniewicz et al., "Recombinant Gamma Interferon Treatment of Pat. with Atopic Dermatitis," Am. J. Medicine:vol. 88 pp. 365-370 (1990).
Adinoff and Clark, "The Allergic Nature of Atopic Dermatitis", Immunology and Allergy Practice, May, pp. 191/17-28/202 (1989).
Sampson, H. A., "Role of Immediate Hypersensitivity in the Pathogenesis of Atopic Dermatitis", Allergy, vol. 44, Suppl. 9, pp. 52-58 (1989).
Ezekowitz et al., "Partial Correction of the Phagocyte Defect . . . by Subcutaneous Interferon Gamma", NEJM, 319:146-151 (Jul. 21), 1988.
Leung Donald
Szefler Stanley
National Jewis Center for Immunology and Respiratory Medicine
Schain Howard E.
Touzeau P. Lynn
LandOfFree
Method for treating a steroid resistant condition via administra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating a steroid resistant condition via administra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating a steroid resistant condition via administra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2093757